Revolution Medicines, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $7.6 Billion | 1/16 | RVMD $7.6B |
BPMC $6.6B |
RNA $3.8B |
KYMR $2.3B |
PTGX $2.2B |
AGIO $1.9B |
NRIX $1.3B |
SANA $634.1M |
STOK $543.4M |
GLUE $387.7M |
CCCC $232.9M |
BDTX $127.9M |
TCRR $58.1M |
PASG $32.1M |
BCEL $3.6M |
FIXX $3.0M |
Gross Margin | 0% | 10/16 | PTGX 100% |
RNA 100% |
NRIX 100% |
GLUE 100% |
BPMC 98% |
AGIO 91% |
CCCC 87% |
STOK 77% |
KYMR 47% |
RVMD 0% |
BCEL 0% |
FIXX 0% |
TCRR 0% |
BDTX 0% |
PASG 0% |
SANA 0% |
Profit Margin | 0% | 2/16 | AGIO 100% |
RVMD 0% |
BCEL 0% |
FIXX 0% |
TCRR 0% |
BDTX 0% |
PASG 0% |
SANA 0% |
BPMC -44% |
PTGX -100% |
STOK -100% |
RNA -100% |
NRIX -100% |
CCCC -100% |
KYMR -100% |
GLUE -100% |
EBITDA margin | -100% | 2/16 | BPMC -26% |
RVMD -100% |
BCEL -100% |
FIXX -100% |
TCRR -100% |
BDTX -100% |
PASG -100% |
SANA -100% |
CCCC -184% |
GLUE -288% |
NRIX -454% |
STOK -517% |
PTGX -887% |
AGIO -1147% |
KYMR -1928% |
RNA -4171% |
Quarterly Revenue | $0 | 10/16 | BPMC $128.2M |
CCCC $15.4M |
NRIX $13.3M |
GLUE $9.2M |
AGIO $9.0M |
STOK $4.9M |
PTGX $4.7M |
KYMR $3.7M |
RNA $2.3M |
RVMD $0 |
BCEL $0 |
FIXX $0 |
TCRR $0 |
BDTX $0 |
PASG $0 |
SANA $0 |
Quarterly Earnings | -$156.3 Million | 16/16 | AGIO $947.9M |
FIXX $1.0M |
BDTX -$15.6M |
PASG -$19.3M |
GLUE -$23.9M |
CCCC -$24.7M |
STOK -$26.4M |
PTGX -$33.2M |
BCEL -$36.2M |
TCRR -$40.4M |
BPMC -$56.3M |
NRIX -$58.5M |
SANA -$59.9M |
KYMR -$62.5M |
RNA -$80.4M |
RVMD -$156.3M |
Quarterly Free Cash Flow | -$133.9 Million | 16/16 | PASG -$7.5M |
BPMC -$13.7M |
FIXX -$14.6M |
BCEL -$17.3M |
GLUE -$21.4M |
STOK -$21.7M |
CCCC -$24.1M |
BDTX -$26.0M |
PTGX -$28.6M |
TCRR -$40.2M |
KYMR -$50.0M |
NRIX -$50.9M |
SANA -$55.9M |
RNA -$67.3M |
AGIO -$84.6M |
RVMD -$133.9M |
Trailing 4 Quarters Revenue | $0 | 11/16 | BPMC $434.4M |
PTGX $323.8M |
KYMR $87.6M |
NRIX $54.5M |
CCCC $33.7M |
AGIO $32.9M |
STOK $16.7M |
GLUE $15.0M |
RNA $10.1M |
FIXX $354,000 |
RVMD $0 |
BCEL $0 |
TCRR $0 |
BDTX $0 |
PASG $0 |
SANA $0 |
Trailing 4 Quarters Earnings | -$538.8 Million | 16/16 | BPMC $128.2M |
CCCC $15.4M |
NRIX $13.3M |
GLUE $9.2M |
AGIO $9.0M |
STOK $4.9M |
PTGX $4.7M |
KYMR $3.7M |
RNA $2.3M |
RVMD -$0 |
BCEL -$0 |
FIXX -$0 |
TCRR -$0 |
BDTX -$0 |
PASG -$0 |
SANA -$0 |
Quarterly Earnings Growth | 9% | 8/16 | AGIO 1138% |
FIXX 104% |
BPMC 58% |
BDTX 32% |
GLUE 32% |
CCCC 31% |
PASG 29% |
RVMD 9% |
PTGX 3% |
STOK -8% |
KYMR -18% |
TCRR -39% |
NRIX -40% |
RNA -54% |
BCEL -57% |
SANA -6190% |
Annual Earnings Growth | -16% | 13/16 | AGIO 297% |
PTGX 214% |
BPMC 76% |
FIXX 35% |
PASG 30% |
CCCC 23% |
GLUE 15% |
BCEL 11% |
SANA 10% |
STOK 9% |
BDTX 9% |
KYMR 1% |
RVMD -16% |
NRIX -27% |
TCRR -45% |
RNA -45% |
Quarterly Revenue Growth | -100% | 15/16 | BPMC 127% |
STOK 48% |
AGIO 21% |
PTGX 0% |
BCEL 0% |
TCRR 0% |
BDTX 0% |
PASG 0% |
CCCC 0% |
SANA 0% |
GLUE 0% |
NRIX -12% |
RNA -17% |
KYMR -21% |
RVMD -100% |
FIXX -100% |
Annual Revenue Growth | -100% | 16/16 | STOK 505% |
CCCC 199% |
BPMC 89% |
KYMR 61% |
AGIO 19% |
RNA 4% |
PTGX 0% |
BCEL 0% |
TCRR 0% |
BDTX 0% |
PASG 0% |
SANA 0% |
GLUE 0% |
NRIX -23% |
FIXX -89% |
RVMD -100% |
Cash On Hand | $201.3 Million | 3/16 | RNA $370.2M |
AGIO $253.7M |
RVMD $201.3M |
STOK $150.0M |
PTGX $131.1M |
SANA $127.0M |
GLUE $125.6M |
FIXX $115.5M |
KYMR $110.7M |
NRIX $110.0M |
BPMC $89.4M |
CCCC $59.6M |
PASG $32.3M |
BDTX $23.4M |
TCRR $14.4M |
BCEL $13.5M |
Short Term Debt | $8.4 Million | 5/16 | BPMC $45.0M |
AGIO $16.3M |
KYMR $12.9M |
SANA $10.6M |
RVMD $8.4M |
NRIX $8.0M |
CCCC $5.6M |
RNA $3.8M |
PASG $3.7M |
GLUE $3.6M |
BDTX $3.3M |
TCRR $3.3M |
FIXX $3.1M |
STOK $2.3M |
BCEL $1.3M |
PTGX $45,000 |
Long Term Debt | $78.3 Million | 3/16 | BPMC $341.5M |
SANA $85.5M |
RVMD $78.3M |
KYMR $75.4M |
CCCC $61.5M |
AGIO $44.5M |
GLUE $40.1M |
PASG $22.1M |
NRIX $20.3M |
BDTX $19.7M |
PTGX $10.9M |
FIXX $6.1M |
RNA $3.8M |
STOK $3.0M |
TCRR $2.7M |
BCEL $0 |
PE | -1.00 | 3/16 | PTGX 13.05 |
AGIO 2.77 |
RVMD -1.00 |
BPMC -1.00 |
BCEL -1.00 |
FIXX -1.00 |
STOK -1.00 |
TCRR -1.00 |
BDTX -1.00 |
PASG -1.00 |
RNA -1.00 |
NRIX -1.00 |
CCCC -1.00 |
KYMR -1.00 |
SANA -1.00 |
GLUE -1.00 |
PS | -1.00 | 11/16 | RNA 375.37 |
AGIO 56.92 |
STOK 32.46 |
KYMR 26.00 |
GLUE 25.89 |
NRIX 24.08 |
BPMC 15.14 |
FIXX 8.48 |
CCCC 6.92 |
PTGX 6.89 |
RVMD -1.00 |
BCEL -1.00 |
TCRR -1.00 |
BDTX -1.00 |
PASG -1.00 |
SANA -1.00 |
PB | 4.83 | 2/16 | BPMC 21.01 |
RVMD 4.83 |
PTGX 4.19 |
KYMR 2.55 |
RNA 2.53 |
NRIX 2.49 |
STOK 2.34 |
SANA 2.17 |
GLUE 1.89 |
BDTX 1.31 |
AGIO 1.15 |
CCCC 0.96 |
TCRR 0.57 |
PASG 0.44 |
BCEL 0.33 |
FIXX 0.06 |
PC | 37.56 | 2/16 | BPMC 73.62 |
RVMD 37.56 |
KYMR 20.56 |
PTGX 17.01 |
NRIX 11.94 |
RNA 10.26 |
AGIO 7.37 |
BDTX 5.46 |
SANA 4.99 |
TCRR 4.02 |
CCCC 3.91 |
STOK 3.62 |
GLUE 3.09 |
PASG 0.99 |
BCEL 0.26 |
FIXX 0.03 |
Liabilities to Equity | 0.13 | 14/16 | BPMC 2.83 |
FIXX 2.12 |
BCEL 1.45 |
SANA 0.91 |
CCCC 0.55 |
PASG 0.54 |
GLUE 0.53 |
TCRR 0.50 |
BDTX 0.42 |
NRIX 0.27 |
STOK 0.26 |
KYMR 0.16 |
PTGX 0.14 |
RVMD 0.13 |
AGIO 0.10 |
RNA 0.09 |
ROA | -0.31 | 8/16 | AGIO 38% | PTGX 28% | BPMC -11% | KYMR -16% | RNA -17% | CCCC -28% | NRIX -29% | RVMD -31% | STOK -36% | GLUE -38% | BDTX -53% | FIXX -55% | SANA -55% | PASG -62% | TCRR -108% | BCEL -361% |
ROE | -0.34 | 5/16 | AGIO 41% |
PTGX 32% |
RNA -19% |
KYMR -19% |
RVMD -34% |
NRIX -37% |
BPMC -41% |
CCCC -43% |
STOK -45% |
GLUE -58% |
BDTX -75% |
PASG -95% |
SANA -105% |
TCRR -161% |
FIXX -170% |
BCEL -884% |
Current Ratio | 8.96 | 3/16 | RNA 11.94 |
AGIO 10.85 |
RVMD 8.96 |
PTGX 8.39 |
KYMR 7.29 |
STOK 4.79 |
NRIX 4.70 |
BDTX 3.41 |
TCRR 3.02 |
GLUE 2.87 |
PASG 2.86 |
CCCC 2.82 |
SANA 2.10 |
BCEL 1.69 |
FIXX 1.47 |
BPMC 1.35 |
Quick Ratio | 7.88 | 2/16 | PTGX 13.05 |
AGIO 2.77 |
RVMD -1.00 |
BPMC -1.00 |
BCEL -1.00 |
FIXX -1.00 |
STOK -1.00 |
TCRR -1.00 |
BDTX -1.00 |
PASG -1.00 |
RNA -1.00 |
NRIX -1.00 |
CCCC -1.00 |
KYMR -1.00 |
SANA -1.00 |
GLUE -1.00 |
Long Term Debt to Equity | 0.05 | 9/16 | BPMC} 1.09 |
PASG} 0.30 |
SANA} 0.29 |
CCCC} 0.25 |
BDTX} 0.20 |
GLUE} 0.19 |
FIXX} 0.13 |
KYMR} 0.08 |
RVMD} 0.05 |
NRIX} 0.04 |
AGIO} 0.03 |
TCRR} 0.03 |
PTGX} 0.02 |
STOK} 0.01 |
BCEL} 0.00 |
RNA} 0.00 |
Debt to Equity | 0.06 | 10/16 | BPMC 1.23 |
PASG 0.36 |
SANA 0.33 |
CCCC 0.28 |
GLUE 0.21 |
BDTX 0.20 |
FIXX 0.19 |
BCEL 0.12 |
KYMR 0.10 |
RVMD 0.06 |
TCRR 0.06 |
NRIX 0.05 |
AGIO 0.04 |
PTGX 0.02 |
STOK 0.01 |
RNA 0.01 |
Burn Rate | 1.25 | 11/16 | STOK 5.53 |
GLUE 4.76 |
RNA 4.54 |
PTGX 3.90 |
CCCC 2.09 |
SANA 1.92 |
NRIX 1.79 |
KYMR 1.61 |
PASG 1.53 |
BDTX 1.36 |
RVMD 1.25 |
BPMC 1.10 |
BCEL 0.37 |
TCRR 0.35 |
AGIO -0.27 |
FIXX -8858.05 |
Cash to Cap | 0.03 | 15/16 | FIXX 38.46 |
BCEL 3.77 |
PASG 1.01 |
GLUE 0.32 |
STOK 0.28 |
CCCC 0.26 |
TCRR 0.25 |
SANA 0.20 |
BDTX 0.18 |
AGIO 0.14 |
RNA 0.10 |
NRIX 0.08 |
PTGX 0.06 |
KYMR 0.05 |
RVMD 0.03 |
BPMC 0.01 |
CCR | 0.86 | 7/16 | BDTX 1.67 |
TCRR 0.99 |
CCCC 0.98 |
SANA 0.93 |
GLUE 0.90 |
NRIX 0.87 |
RVMD 0.86 |
PTGX 0.86 |
RNA 0.84 |
STOK 0.82 |
KYMR 0.80 |
BCEL 0.48 |
PASG 0.39 |
BPMC 0.24 |
AGIO -0.09 |
FIXX -14.14 |
EV to EBITDA | -1.00 | 2/16 | FIXX} 6.96 |
RVMD} -1.00 |
BCEL} -1.00 |
TCRR} -1.00 |
BDTX} -1.00 |
PASG} -1.00 |
SANA} -1.00 |
CCCC} -8.51 |
GLUE} -11.53 |
STOK} -15.63 |
AGIO} -16.32 |
NRIX} -20.41 |
KYMR} -31.25 |
RNA} -35.26 |
PTGX} -50.90 |
BPMC} -206.03 |
EV to Revenue | -1.00 | 10/16 | RNA 339.53 |
AGIO 51.06 |
KYMR 25.74 |
STOK 23.64 |
NRIX 22.58 |
GLUE 20.42 |
BPMC 15.83 |
CCCC 7.14 |
PTGX 6.52 |
RVMD -1.00 |
BCEL -1.00 |
TCRR -1.00 |
BDTX -1.00 |
PASG -1.00 |
SANA -1.00 |
FIXX -291.86 |